On September 18 and 19, 2025, the U.S. Food and Drug Administration (FDA) is hosting a virtual public workshop to discuss methodological challenges related to patient experience data encountered, including the submission and evaluation of patient experience data in the context of the benefit-risk assessment and product labeling, as well as other ar
Similar Posts
Chemspec Chemicals Private Limited – 718403 – 12/23/2025
CGMP/Active Pharmaceutical Ingredient (API)/AdulteratedCovalent Medical – 695839 – 07/09/2025
Unapproved New Drugs/MisbrandedAdvancing Real-World Evidence Program
Advancing Real-World Evidence ProgramRight Value Drug Stores, LLC. Irving, TX. 483 issued 07/18/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 07/18/2025
Short Title (70 char) Right Value Drug Stores, LLC. Irving, TX. 483 issued 07/18/2025
FEI Number 3010589333
Firm Name Right Value Drug Stores, LLC
Record Type 483
State TX
Establishment Type OutsourciDrug Safety Communications
FDA Drug Safety Communications connect consumers and health care professionals to important drug safety information. The webpage contains the most recent Drug Safety Communications from FDA as well as links for Early Communications, Follow-Up Early Communications, Information for Healthcare ProfessiWILDMAN may be harmful due to hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use WILDMAN, a product promoted and sold for sexual enhancement on various websites, including www.loveproducts.net, and possibly in some retail stores.